Transforming cancer care in India: The Access Cancer Care Initiative
Prof Shaw talks to ecancertv at IAOO 2015 about the international perspective on HPV prevention and how this is being fed into government policies.
Controversial international perspective on HPV prevention
Prof Richard Shaw - University of Liverpool Cancer Research Centre, Liverpool, UK
What is the international perspective on HPV prevention?
The acceptance that HPV is a significant cause of head and neck cancer has been slow to feed into government policy on vaccination and it’s quite a controversial area. So in some countries they’ve spread the vaccination to boys and girls because, as you may be aware, it’s boys are predisposed to eventually developing HPV oropharynx cancer, not girls. In the UK we’ve got a programme of vaccination for girls which is very effective and is directed against preventing cervical cancer and we’re at the moment in the discussion, as an academic body, about whether extending the vaccination to boys is a worthwhile health benefit.
In other parts of the world the girl vaccination programme isn’t as successful and is patchy and, of course, in other parts of the world there is no vaccination programme. The problem in the third world in cervical cancer is that there’s a huge burden of disease, much of which is fatal, and there’s no vaccination programme and it’s worth highlighting that in any discussion.
Transforming cancer care in India: The Access Cancer Care Initiative
Advancements in head and neck cancer treatment in India
Enhancing head and neck oncology: Key insights from the conference
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Psychological issues in familial cancer
GIST tumours and soft tissue sarcomas
Importance of MRD in newly developed multiple myeloma
Best practice in HRRm testing in patients with metastatic prostate cancer